Synonyms for progressiva or Related words with progressiva

fibrodysplasia              ossificans              dyschondrosteosis              enchondromatosis              acromesomelic              achondropasia              calcinoisis              otopalatodigital              echondromata              dyskeratosis              hidrotic              echondromatosis              osteodysplasia              chondrodystrophia              chondrodystrophy              faciogenital              fibromatosis              hypochondroplasia              achondroplasia              osteogenese              hyprochondroplasia              congenitalis              spondylocostal              acromelanosis              calcificans              ossifcans              chondrodysplasia              neurocutaneous              dolichostenomelia              frontofacionasal              spondyloepiphyseal              osteopathia              osteopetrosis              osteochondroma              rhizomelic              cherubism              osteopoikilosis              osteosclerosis              nephronophthisis              hyperostosis              spondylarthritis              osteitis              marfan              exostosis              protuberans              myofibromatosis              pilomatricoma              xanthomatosis              progeria              thanatophoric             

Examples of "progressiva"
and suggested new name "encephaloleukopathia scleroticans progressiva".
C. Belloli, "Marina Apollonio: anticampi cromoformali ottico rotatori/cinestensivi a radiazione progressiva", Arte Struktura, Milan
It has also been alternatively called "dyssynergia cerebellaris myoclonica", "dyssynergia cerebellaris progressiva", dentatorubral degeneration, or Ramsay Hunt cerebellar syndrome.
Increase in expression of BMP4 has been associated with a variety of bone diseases, including the heritable disorder Fibrodysplasia Ossificans Progressiva.
From the late 1980's, along with Dr. Fred Kaplan (University of Pennsylvania), Dr. Zasloff began research on the cause and treatment of Fibrodysplasia Ossificans Progressiva (FOP).
In 2006, Drs. Kaplan and Shore of the Department of Orthopedics discovered the causative mutation in fibrodysplasia ossificans progressiva, an extremely rare disease of bone.
All the money raised by FOP Friends goes directly to supporting the research into finding a treatment and a cure for Fibrodysplasia Ossificans Progressiva.
FOP Friends' chairman, Chris Bedford-Gay is one of the co-authors of the medical article "The Natural History of Flare-Ups in Fibrodysplasia Ossificans Progressiva (FOP): A Comprehensive Global Assessment."
The International Fibrodysplasia Ossificans Progressiva Association (IFOPA) is a US-based 501(c)(3) non-profit organization supporting medical research, education and communication for those afflicted by the rare genetic condition Fibrodysplasia Ossificans Progressiva (FOP). IFOPA’s mission is to fund research to find a cure for FOP while supporting, connecting, and advocating for individuals with FOP and their families, and raising awareness worldwide. IFOPA is governed by a volunteer board of directors which may range in number from 9 to 15, at least one of whom must have FOP. The association's location is 1520 Clay St., Suite H2, North Kansas City, part of the Kansas City, Missouri metropolitan area.
FOP Friends, formerly Friends of Oliver, is a registered charity in the United Kingdom established on 1 March 2012. It aims to raise funds that are needed to find effective treatments for the rare genetic condition Fibrodysplasia Ossificans Progressiva (FOP). The charity also works to raise awareness and understanding of FOP amongst medical communities and the general public.
In 1894 he described a condition he called "encephalitis subcorticalis chronica progressiva", which would later go by the name of "Binswanger disease". This disease is defined as subcortical dementia characterized by loss of memory and intellectual faculties. One of his more famous patients was German philosopher Friedrich Nietzsche, others were the writers (later on) Hans Fallada and Johannes R. Becher.
Idiopathic guttate hypomelanosis (also known as "Leukopathia symmetrica progressiva") is a very common acquired disorder that affects women more frequently than men, presenting with skin lesions that occur chiefly on sun exposed regions of the skin, suggesting sun exposure may play a role.
Medical reports describing individuals affected by FOP date back as far as the seventeenth century. FOP was originally called myositis ossificans progressiva and was thought to be caused by muscular inflammation (myositis) that caused bone formation. The disease was renamed by Victor A. McKusick in 1970 following the discovery that soft tissue other than muscles (e.g., ligaments) were also affected by the disease process.
Keratitis–ichthyosis–deafness syndrome (also known as "Erythrokeratodermia progressiva Burns," "Ichthyosiform erythroderma, corneal involvement, and deafness," and "KID syndrome,") presents at birth/infancy and is characterized by pregressive corneal opacification, either mild generalized hyperkeratosis or discrete erythematous plaques, and neurosensory deafness.
Palovarotene is a highly selective retinoic acid receptor gamma (RAR-γ) agonist that is under investigation as a potential treatment for fibrodysplasia ossificans progressiva (FOP), an ultra-rare and severely disabling genetic disease characterized by extra-skeletal bone formation (heterotopic ossification or HO) in muscle and soft tissues.
Progressive symmetric erythrokeratodermia (also known as "Erythrokeratodermia progressiva symmetrica") is a rare, autosomal dominant skin condition that manifests soon after birth with erythematous, hyperkeratotic plaques that are symmetrically distributed on the extremities, buttocks, and face, but sparing the trunk. No other clinical symptoms nor mental or physical signs are usually associated with the condition.
It is also somewhat effective for hidradenitis suppurativa and some cases of severe acne rosacea. It can also be used to help treat harlequin ichthyosis, lamellar ichthyosis and is used in xeroderma pigmentosum cases to relieve keratoses. Isotretinoin has been used to treat the extremely rare condition fibrodysplasia ossificans progressiva. It is also used for treatment of neuroblastoma, a form of nerve cancer.
Schamberg Disease, (also known as "Progressive pigmentary dermatosis of Schamberg", "Purpura pigmentosa progressiva" (PPP), and "Schamberg's purpura") is a chronic discoloration of the skin found in people of all ages, usually affecting the legs. It slowly spreads throughout the body, and is most common in males. It is named after Jay Frank Schamberg, who described it in 1901.
There are also rare genetic disorders causing heterotopic ossification such as fibrodysplasia ossificans progressiva (FOP), a condition that causes injured bodily tissues to be replaced by heterotopic bone. Characteristically exhibiting in the big toe at birth, it causes the formation of heterotopic bone throughout the body over the course of the sufferer's life, causing chronic pain and eventually leading to the immobilisation and fusion of most of the skeleton by abnormal growths of bone.
Fibrodysplasia ossificans progressiva (FOP) is an extremely rare connective tissue disease. The disease is caused by a mutation of the body's repair mechanism, which causes fibrous tissue (including muscle, tendon, and ligament) to be ossified spontaneously or when damaged. In many cases, injuries can cause joints to become permanently frozen in place. Surgical removal of the extra bone growths has been shown to cause the body to "repair" the affected area with even more bone.